Stock Market Live June 8, 2026: S&P 500 (SPY) Rebounds with Chip Stocks
Q2 26 EPS
$N/A
Q2 26 Revenue
N/A
vs S&P Since Q2 26
+18.3%
BEATING MARKET
DOC +19.3% vs S&P +1.0%
Market Reaction
Did DOC Beat Earnings? Q2 2026 Results
Healthpeak Properties delivered a standout first quarter for 2026, with GAAP earnings of $0.28 per diluted share clearing the $0.05 consensus estimate by 456.66% and revenue of $752.95 million beating expectations by 8.63% while rising 7.1% year over… Read more Healthpeak Properties delivered a standout first quarter for 2026, with GAAP earnings of $0.28 per diluted share clearing the $0.05 consensus estimate by 456.66% and revenue of $752.95 million beating expectations by 8.63% while rising 7.1% year over year. The primary driver behind the earnings beat was $138.12 million in gains upon change of control, tied to the acquisition of a joint venture partner's 46.5% interest in 19 senior housing properties and the partial disposition of six outpatient medical buildings. The quarter was further defined by the IPO of Janus Living, Inc., Healthpeak's senior housing subsidiary, which generated roughly $880.00 million in net proceeds and carries a market capitalization of $6.90 billion, with Healthpeak retaining an 81.6% stake. Segment performance was mixed, as Senior Housing same-store cash NOI surged 13.8% while Lab declined 7.2%, though Lab occupancy is expected to climb through year-end. Management raised full-year 2026 EPS guidance to $0.46 to $0.50 and lifted FFO as Adjusted guidance to $1.71 to $1.75, signaling continued confidence in the portfolio's trajectory.
Key Takeaways
- • Janus Living IPO completed at high end of valuation range, generating approximately $880 million in net proceeds
- • Senior housing same-store cash NOI growth of 13.8% year-over-year
- • Outpatient Medical same-store cash NOI growth of 2.4% year-over-year
- • Gain upon change of control of $138 million related to senior housing JV acquisition and outpatient medical JV disposition
- • Gain on sales of real estate of $50.7 million
- • Resident fees and services grew to $200.3 million from $148.9 million year-over-year driven by senior housing acquisitions
DOC Forward Guidance & Outlook
Healthpeak raised full-year 2026 diluted EPS guidance to $0.46–$0.50 (from $0.34–$0.38), raised FFO as Adjusted per share guidance to $1.71–$1.75 (from $1.70–$1.74), and lowered Nareit FFO per share guidance to $1.68–$1.72 (from $1.70–$1.74). The company reaffirmed full-year 2026 Total Same-Store Cash (Adjusted) NOI growth in the range of (1.0%) to 1.0%. Lab total occupancy is expected to increase through year-end 2026. Janus Living is under contract on approximately $400 million of incremental senior housing acquisitions.
DOC YoY Financials
Q2 2026 vs Q2 2025, source: SEC Filings
DOC Revenue by Segment
With YoY comparisons, source: SEC Filings
DOC Earnings Trends
DOC vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
DOC EPS Trend
Earnings per share: estimate vs actual
DOC Revenue Trend
Quarterly revenue: estimate vs actual
DOC Quarterly Results
6 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q2 26 | — | — | — | — | — |
| Q1 26 BEAT | $0.05 | $0.28 | +456.66% | $753.0M | +8.63% |
| Q4 25 BEAT FY | $0.07 | $0.16 | +132.90% | $719.4M | +12.10% |
| FY Full Year | $-0.01 | $0.10 | +1,100.00% | $2.82B | +2.83% |
| Q3 25 MISS | $0.06 | $-0.17 | -383.33% | $705.9M | +3.65% |
| Q2 25 MISS | $0.06 | $0.05 | -11.82% | $694.3M | +0.11% |
| Q1 25 BEAT | $0.05 | $0.06 | +33.33% | $702.9M | +1.98% |